is zepbound a glp 1 drug Use of the dual GIP/GLP-1 tirzepatide (Mounjaro, Zepbound) was associated with significantly reduced risk of glaucoma compared with GLP-1 drugs among patients with type 2 diabetes, a large retrospective cohort Zepbound Lawsuit [2026] | Gastrointestinal
Pay in 4 interest-free payments of $6.91 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
![is zepbound a glp 1 drug Use of the dual GIP/GLP-1 tirzepatide (Mounjaro, Zepbound) was associated with significantly reduced risk of glaucoma compared with GLP-1 drugs among patients with type 2 diabetes, a large retrospective cohort Zepbound Lawsuit [2026] | Gastrointestinal](https://www.torhoermanlaw.com/wp-content/uploads/2026/02/Zepbound-Lawsuit-Other-Drugs-and-Manufacturers-Named-in-the-GLP-1-Lawsuits-torhoerman-law.jpg)
![is zepbound a glp 1 drug Use of the dual GIP/GLP-1 tirzepatide (Mounjaro, Zepbound) was associated with significantly reduced risk of glaucoma compared with GLP-1 drugs among patients with type 2 diabetes, a large retrospective cohort Zepbound Lawsuit [2026] | Gastrointestinal](https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/Zepbound%20Vials%201.png?VersionId=TeVfAfJgDOm0I3d5ocf39HAZ2bASHILG)
![is zepbound a glp 1 drug Use of the dual GIP/GLP-1 tirzepatide (Mounjaro, Zepbound) was associated with significantly reduced risk of glaucoma compared with GLP-1 drugs among patients with type 2 diabetes, a large retrospective cohort Zepbound Lawsuit [2026] | Gastrointestinal](https://weightlossnyc.com/diet/oksana_aron_M.D._GLP-1_weightloss.jpg)
![is zepbound a glp 1 drug Use of the dual GIP/GLP-1 tirzepatide (Mounjaro, Zepbound) was associated with significantly reduced risk of glaucoma compared with GLP-1 drugs among patients with type 2 diabetes, a large retrospective cohort Zepbound Lawsuit [2026] | Gastrointestinal](https://whyy.org/wp-content/uploads/2025/05/wegovy-zepbound-768x512.jpg)

























